Item Details

H-003 / H-003-1MLUpdated item number format

Hydrocodone
1.0 mg/mL in Methanol | Certified Reference Material

Hydrocodone is a semi-synthetic opioid derived from codeine or thebaine, two naturally-occurring opiates. The drug, also known as dihydrocodeinone, is used as an analgesic to treat pain and as an antitussive for coughing or related conditions. This Certified Spiking Solution® is suitable as a starting material for calibrators or controls in GC/MS or LC/MS testing applications from pharmaceutical research and pain prescription monitoring to clinical toxicology and forensic analysis.

Concentration
:    1.0 mg/mL
Solvent
:    Methanol
Unit Size
:    1 mL/ampoule
CAS Number
:    125-29-1
Chemical Formula:
:    C18H21NO3
Molecular Weight:
:    299.36
Certificate of Analysis
US List Price
$29.50 EA
Quantity
**Eligible Discounts Applied at Checkout**
Product Image
H-005 / H-005-1ML Hydrocodone-D3, 100 μg/mL $41.00
H-008 / H-008-1ML Hydrocodone-D3, 1.0 mg/mL $163.00
H-047 / H-047-1ML Hydrocodone-D6, 100 μg/mL $46.20
H-048 / H-048-1ML Hydrocodone-D6, 1.0 mg/mL $175.00
N-053 / N-053-1ML Norhydrocodone HCl, 1.0 mg/mL (as free base) $123.00
N-054 / N-054-1ML Norhydrocodone-D3 HCl, 100 μg/mL (as free base) $156.00
O-020 / O-020-1ML Opiate Multi-Component Mixture-5, 250 μg/mL of each component $175.00
P-071 / P-071-1ML Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl $471.00

Regulatory Control

▶  USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶  Canada Test Kit Registration # 61-1213 - no Health Canada import authorization required

Recommended Storage Condition

Freeze

UN Number, Class, PG

1230, 3, II

Safety Data Sheet

HS Code

3822.90.0000
A High-throughput Pain Management Panel in Urine Using IONICS 3Q 120 LC-MS/MS and an SLE Sample Prep Platform | IONICS Mass Spectrometry Group inc., 2014
Advanced Toxicology Testing for Compounds using Core-Shell Technology | Erica A. Guice, Jessica Marsh, Seyed Sajadi, and Matthew Pentis, Western Slope Laboratory, 2012
An Automated Solid Phase Extraction Method for Opiates in Urine | Jeffery Hackett and Michael Telepchak, UCT, Inc., 2012
Comparison of Forensic Tandem Mass Spectral Data Obtained on Portable Instrumentation to an Established Reference Library | Adam E. O’Leary, Seth E. Hall, Herbert M. Oberacher, andChristopher C. Mulligan, llinois State University Department of Chemistry, 2014
Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µElution SPE Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
LC-MS (TOF) Analysis of Opioids and Opiate-Dependence Management Drugs on Ascentis® Express HILIC | Sigma-Aldrich®, 2014
LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
LC/MS (TOF) Analysis of Opioid Drugs and Glucuronide Metabolites in Urine on Ascentis® Express 2.7 µm HILIC after SPE using Supel™-Select HLB, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
LC/MS Analysis of Opioid Glucuronide Metabolites in Urine on Ascentis® Express 2.7 µm F5 after Solid Phase Extraction (SPE) using Supel™-Select HLB | Sigma-Aldrich®, 2014
LC/MS/MS Analysis of Drugs of Abuse: Generic Screening on Ascentis® Express F5 | Sigma-Aldrich®, 2015
Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
Proof of Concept/Comparison of Automated SPE/HPLC/MS/MS Methods to Traditional Immunoassay with MS Confirmation in Death Investigation Cases | Robert M. Sears, Wendy C. Bell , Kenneth C. Lewis, Thurman L. Allsup and Kim Gamble, ITSP Solutions, INC., 2014
Rapid Differentiation of Isobaric Drugs Using a Novel Direct Sample Analysis Source, CID, and Accurate Mass TOF Mass Spectrometry | Robert J. Seward, Bonnie Marmor, and Andrew Tyler, PerkinElmer, Inc., 2014